Literature DB >> 26391903

Different Methods to Measure QRS Duration in CRT Patients: Impact on the Predictive Value of QRS Duration Parameters.

Jan De Pooter1, Milad El Haddad1, Liesbeth Timmers1, Frédéric Van Heuverswyn1, Luc Jordaens1, Mattias Duytschaever1,2, Roland Stroobandt1.   

Abstract

BACKGROUND: Measurements of QRS duration (QRSD) in patients undergoing cardiac resynchronization therapy (CRT) are not standardized. We hypothesized that both the measurement of QRSD and its predictive value on CRT response are sensitive to the method by which QRSD is measured.
METHODS: Electrocardiograms (ECGs) pre- and post-CRT from 52 CRT patients (66 ± 12 years, 65% male) were retrospectively analyzed. Custom-made software was developed to measure global QRSD (QRSDglobal ) and lead-specific QRSD (QRSDI,II,III,aVR,aVL,aVF,V1,V2,V3,V4,V5,V6 ). QRSD was also assessed automatic by a routinely used ECG device. For each method we measured QRSD pre- and post-CRT and shortening of QRSD (∆QRSD). Response to CRT at 6 months was defined as an improvement of ≥1 class in New York Heart Association classification and an increase by >7.5% in left ventricular ejection fraction.
RESULTS: The CRT response rate was 77% (n = 40). Different methods to measure QRSD show divergent nominal values before (median range 152-172 ms, P < 0.001) and after CRT (130-152 ms, P < 0.001). The predictive value of QRSD measurements for CRT response also varies significantly according to the method used (range AUC pre-CRT QRSD 0.400-0.580, P < 0.05; AUC post-CRT QRSD 0.447-0.768, P < 0.05; AUC ΔQRSD 0.540-0.858, P < 0.05). Global QRSD measurements revealed lower variability compared to lead-specific QRSD.
CONCLUSION: Different methods to measure QRSD yield not only different nominal values but also influence the value of QRSD in predicting CRT response. Measuring QRSD by a global method can help to standardize QRSD measurements in future studies.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ECG-analysis; QRS duration; cardiac resynchronization therapy; electrocardiography; observer variation

Mesh:

Year:  2015        PMID: 26391903      PMCID: PMC6931560          DOI: 10.1111/anec.12313

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  21 in total

1.  Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy.

Authors:  Maxime De Guillebon; Jean-Benoit Thambo; Sylvain Ploux; Antoine Deplagne; Frederic Sacher; Pierre Jais; Michel Haissaguerre; Philippe Ritter; Jacques Clementy; Pierre Bordachar
Journal:  J Cardiovasc Electrophysiol       Date:  2010-03-04

Review 2.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.

Authors:  Borys Surawicz; Rory Childers; Barbara J Deal; Leonard S Gettes; James J Bailey; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Pentti M Rautaharju; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  Circulation       Date:  2009-02-19       Impact factor: 29.690

3.  Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.

Authors:  Ilke Sipahi; Thomas P Carrigan; Douglas Y Rowland; Bruce S Stambler; James C Fang
Journal:  Arch Intern Med       Date:  2011-06-13

4.  Delayed intrinsicoid deflection onset in surface ECG lateral leads predicts left ventricular reverse remodeling after cardiac resynchronization therapy.

Authors:  Freddy Del-Carpio Munoz; Brian D Powell; Yong-Mei Cha; Heather J Wiste; Margaret M Redfield; Paul A Friedman; Samuel J Asirvatham
Journal:  Heart Rhythm       Date:  2013-03-28       Impact factor: 6.343

5.  Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure.

Authors:  Guillaume Lecoq; Christophe Leclercq; Emmanuelle Leray; Christophe Crocq; Christine Alonso; Christian de Place; Philippe Mabo; Claude Daubert
Journal:  Eur Heart J       Date:  2005-02-23       Impact factor: 29.983

6.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Theresa McDonagh; Udo Sechtem; Luis Almenar Bonet; Panayiotis Avraamides; Hisham A Ben Lamin; Michele Brignole; Antonio Coca; Peter Cowburn; Henry Dargie; Perry Elliott; Frank Arnold Flachskampf; Guido Francesco Guida; Suzanna Hardman; Bernard Iung; Bela Merkely; Christian Mueller; John N Nanas; Olav Wendelboe Nielsen; Stein Orn; John T Parissis; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2012-08       Impact factor: 15.534

7.  A novel electrocardiographic predictor of clinical response to cardiac resynchronization therapy.

Authors:  Roberto Mollo; Alessandro Cosenza; Ilaria Coviello; Alessandra Stazi; Giulio Russo; Angelo Villano; Alfonso Sestito; Gianluigi Bencardino; Gaetano A Lanza; Filippo Crea
Journal:  Europace       Date:  2013-06-20       Impact factor: 5.214

8.  Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.

Authors:  Frederic A Sebag; Raphael P Martins; Pascal Defaye; Françoise Hidden-Lucet; Philippe Mabo; Jean-Claude Daubert; Christophe Leclercq
Journal:  J Cardiovasc Electrophysiol       Date:  2012-06-14

9.  Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy.

Authors:  David R Tomlinson; Yaver Bashir; Timothy R Betts; Kim Rajappan
Journal:  Europace       Date:  2009-01-26       Impact factor: 5.214

10.  Results of the Predictors of Response to CRT (PROSPECT) trial.

Authors:  Eugene S Chung; Angel R Leon; Luigi Tavazzi; Jing-Ping Sun; Petros Nihoyannopoulos; John Merlino; William T Abraham; Stefano Ghio; Christophe Leclercq; Jeroen J Bax; Cheuk-Man Yu; John Gorcsan; Martin St John Sutton; Johan De Sutter; Jaime Murillo
Journal:  Circulation       Date:  2008-05-05       Impact factor: 29.690

View more
  5 in total

1.  Precision of automated QRS duration measurement in patients treated with cardiac resynchronization therapy.

Authors:  Casper Lund-Andersen; Helen H Petersen; Christian Jøns; Berit T Philbert; Jacob Tfelt-Hansen; Lene T Skovgaard; Jesper H Svendsen
Journal:  J Interv Card Electrophysiol       Date:  2018-03-05       Impact factor: 1.900

2.  Narrowing filtered QRS duration on signal-averaged electrocardiogram predicts outcomes in cardiac resynchronization therapy patients with nonischemic heart failure.

Authors:  Atsushi Suzuki; Tsuyoshi Shiga; Daigo Yagishita; Yoshimi Yagishita-Tagawa; Kotaro Arai; Yuji Iwanami; Koichiro Ejima; Kyomi Ashihara; Morio Shoda; Nobuhisa Hagiwara
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-11-30       Impact factor: 1.468

3.  Reduction in the QRS area after cardiac resynchronization therapy is associated with survival and echocardiographic response.

Authors:  Mohammed A Ghossein; Antonius M W van Stipdonk; Filip Plesinger; Mariëlle Kloosterman; Philippe C Wouters; Odette A E Salden; Mathias Meine; Alexander H Maass; Frits W Prinzen; Kevin Vernooy
Journal:  J Cardiovasc Electrophysiol       Date:  2021-01-28

4.  Vectorcardiographic QRS area as a predictor of response to cardiac resynchronization therapy.

Authors:  Mohammed A Ghossein; Antonius Mw van Stipdonk; Frits W Prinzen; Kevin Vernooy
Journal:  J Geriatr Cardiol       Date:  2022-01-28       Impact factor: 3.327

5.  Left Ventricular Lead Placement Guided by Reduction in QRS Area.

Authors:  Mohammed Ali Ghossein; Francesco Zanon; Floor Salden; Antonius van Stipdonk; Lina Marcantoni; Elien Engels; Justin Luermans; Sjoerd Westra; Frits Prinzen; Kevin Vernooy
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.